Nanoviricides, INC.
Clinical-stage development of antiviral nanomedicines
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
NanoViricides creates investigational nanomedicines intended to treat patients with viral infections. Its development pipeline includes NV-387, a broad-spectrum antiviral candidate, and NV-HHV-1 for shingles and related herpes infections. The company advances these therapies through research and clinical trials.
At a Glance
Nanoviricides, INC. is an American manufacturer based in Shelton, CT.
- Where
- Shelton, CT
